NASDAQ : CTMX

CytomX Therapeutics, Inc. — Stock Grades

$3.17 USD

$0.07 (2.26%)

Volume
3.8M
Average Volume
4.14M
Market Capitalization
$509.81M
P/E Ratio
-8.78
Dividend Yield
0.00%
Price Target
$11.50
Year High
$8.21
Year Low
$1.72
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$10.38
CTMX Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-05-11 HC Wainwright & Co. Buy Buy Maintain
2026-03-23 Piper Sandler Overweight Overweight Maintain
2026-03-19 Barclays Overweight Overweight Maintain
2026-03-18 Guggenheim Buy Buy Maintain
2026-03-18 Jefferies Buy Buy Maintain
2026-03-17 Wedbush Outperform Outperform Maintain
2026-03-16 HC Wainwright & Co. Buy Buy Maintain
2026-03-16 JP Morgan Neutral Overweight Upgrade
2026-03-09 Guggenheim Buy Buy Maintain
2026-02-04 Barclays Overweight Overweight Maintain
2026-02-04 Cantor Fitzgerald Overweight Overweight Maintain
2026-01-20 Barclays Overweight Overweight Maintain
2026-01-20 Piper Sandler Overweight Overweight Maintain